17:27 EDT Compass Therapeutics files $300M mixed securities shelf
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CMPX:
- Compass Therapeutics Reports 2024 Second Quarter Financial Results and Provides Corporate Update
- Compass Therapeutics reports Q2 EPS (10c), consensus (9c)
- Compass Therapeutics to Participate in the Wedbush PacGrow Healthcare Conference
- Compass Therapeutics completes patient enrollment in COMPANION-002